Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Inventory (2016 - 2023)

Historic Inventory for Lexaria Bioscience (LEXX) over the last 9 years, with Q1 2023 value amounting to $7588.0.

  • Lexaria Bioscience's Inventory fell 7623.33% to $7588.0 in Q1 2023 from the same period last year, while for Feb 2023 it was $7588.0, marking a year-over-year decrease of 7623.33%. This contributed to the annual value of $38418.0 for FY2022, which is 2958.04% up from last year.
  • Lexaria Bioscience's Inventory amounted to $7588.0 in Q1 2023, which was down 7623.33% from $9936.0 recorded in Q4 2022.
  • In the past 5 years, Lexaria Bioscience's Inventory registered a high of $188275.0 during Q2 2019, and its lowest value of -$6067.0 during Q4 2020.
  • Over the past 5 years, Lexaria Bioscience's median Inventory value was $45960.5 (recorded in 2021), while the average stood at $74440.8.
  • As far as peak fluctuations go, Lexaria Bioscience's Inventory crashed by 10454.27% in 2020, and later soared by 54447.01% in 2021.
  • Lexaria Bioscience's Inventory (Quarter) stood at $133556.0 in 2019, then crashed by 104.54% to -$6067.0 in 2020, then soared by 544.47% to $26966.0 in 2021, then crashed by 63.15% to $9936.0 in 2022, then dropped by 23.63% to $7588.0 in 2023.
  • Its Inventory was $7588.0 in Q1 2023, compared to $9936.0 in Q4 2022 and $38418.0 in Q3 2022.